James E. Riggs
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
James E. Riggs has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
John Somerville
Department of Biology, Rider University, Lawrenceville, NJ 08648, USA
6 shared publicationsNaomi Goldman
Department of Biology, Rider University, Lawrenceville, NJ 08648, USA
6 shared publicationsAmanda Bucknum
Department of Biology, Rider University, Lawrenceville, NJ, 08648, USA
3 shared publicationsDaniel Silberman
Department of Biology, Rider University, Lawrenceville, NJ 08648, USA
3 shared publicationsJeffrey Maslanka
Department of Biology, Rider University, Lawrenceville, NJ 08648, USA
3 shared publications- Jennifer Londregan
Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA
3 shared publications
Latest Publications
- 22 November 2023
- Published by Elsevier in Cellular Immunology
- Vol. 395-396, 104788
Loss of B1 and marginal zone B cells during ovarian cancer
- 22 November 2023
- Published by Elsevier in Cellular Immunology
- Vol. 395-396, 104788
Loss of B1 and marginal zone B cells during ovarian cancer
- 20 January 2022
- Published by Elsevier in Immunobiology
- Vol. 227 (2) , 152181
IgD ligation allows peritoneal cavity B cell proliferation
- 20 January 2022
- Published by Elsevier in Immunobiology
- Vol. 227 (2) , 152181
IgD ligation allows peritoneal cavity B cell proliferation
- 1 January 2019
- Published by Elsevier in Immunobiology
- Vol. 224 (1) , 94-101
PHA eludes macrophage suppression to activate CD8+ T cells
- 1 January 2019
- Published by Elsevier in Immunobiology
- Vol. 224 (1) , 94-101
PHA eludes macrophage suppression to activate CD8+ T cells
- 1 February 2018
- Published by Elsevier in Cellular Immunology
- Vol. 324, 50-58
High macrophage PD-L1 expression not responsible for T cell suppression
- 1 February 2018
- Published by Elsevier in Cellular Immunology
- Vol. 324, 50-58
High macrophage PD-L1 expression not responsible for T cell suppression
- 1 April 2017
- Published by Elsevier in Cellular Immunology
- Vol. 314, 54-62
Macrophage regulation of B cell proliferation
- 1 April 2017
- Published by Elsevier in Cellular Immunology
- Vol. 314, 54-62
Macrophage regulation of B cell proliferation
- 1 August 2016
- Published by Elsevier in Cellular Immunology
- Vol. 306-307, 17-24
Erythropoietin increases macrophage-mediated T cell suppression
- 1 August 2016
- Published by Elsevier in Cellular Immunology
- Vol. 306-307, 17-24
Erythropoietin increases macrophage-mediated T cell suppression
- Open Access
- 1 January 2013
- Published by Taylor & Francis in Journal of Oral Microbiology
- Vol. 5 (1)
Porphyromonas gingivalis: keeping the pathos out of the biont
Porphyromonas gingivalis : keeping the pathos out of the biont
- 1 January 2013
- Published by Taylor & Francis in Journal of Oral Microbiology
- Vol. 5 (1)
Open AccessPorphyromonas gingivalis: keeping the pathos out of the biont
Porphyromonas gingivalis : keeping the pathos out of the biont
- 23 April 2012
- Published by Springer Nature in Cellular & Molecular Immunology
- Vol. 9 (4) , 341-349
CD28 ligation increases macrophage suppression of T-cell proliferation
When compared to spleen or lymph node cells, resident peritoneal cavity cells respond poorly to T-cell activation in vitro. The greater proportional representation of macrophages in this cell source has been shown to actively suppress the T-cell response. Peritoneal macrophages exhibit an immature phenotype (MHC class IIlo, B7lo) that reduces their efficacy as antigen-presenting cells. Furthermore, these cells readily express inducible nitric oxide synthase (iNOS), an enzyme that promotes T-cell tolerance by catabolism of the limiting amino acid arginine. Here, we investigate the ability of exogenous T-cell costimulation to recover the peritoneal T-cell response. We show that CD28 ligation failed to recover the peritoneal T-cell response and actually suppressed responses that had been recovered by inhibiting iNOS. As indicated by cytokine ELISpot and neutralizing monoclonal antibody (mAb) treatment, this ‘cosuppression’ response was due to CD28 ligation increasing the number of interferon (IFN)-γ-secreting cells. Our results illustrate that cellular composition and cytokine milieu influence T-cell costimulation biology.
- 23 April 2012
- Published by Springer Nature in Cellular & Molecular Immunology
- Vol. 9 (4) , 341-349
CD28 ligation increases macrophage suppression of T-cell proliferation
When compared to spleen or lymph node cells, resident peritoneal cavity cells respond poorly to T-cell activation in vitro. The greater proportional representation of macrophages in this cell source has been shown to actively suppress the T-cell response. Peritoneal macrophages exhibit an immature phenotype (MHC class IIlo, B7lo) that reduces their efficacy as antigen-presenting cells. Furthermore, these cells readily express inducible nitric oxide synthase (iNOS), an enzyme that promotes T-cell tolerance by catabolism of the limiting amino acid arginine. Here, we investigate the ability of exogenous T-cell costimulation to recover the peritoneal T-cell response. We show that CD28 ligation failed to recover the peritoneal T-cell response and actually suppressed responses that had been recovered by inhibiting iNOS. As indicated by cytokine ELISpot and neutralizing monoclonal antibody (mAb) treatment, this ‘cosuppression’ response was due to CD28 ligation increasing the number of interferon (IFN)-γ-secreting cells. Our results illustrate that cellular composition and cytokine milieu influence T-cell costimulation biology.
- 1 January 2011
- Published by Elsevier in Immunobiology
- Vol. 216 (1-2) , 256-264
Peritoneal T lymphocyte regulation by macrophages
- 1 January 2011
- Published by Elsevier in Immunobiology
- Vol. 216 (1-2) , 256-264
Peritoneal T lymphocyte regulation by macrophages
- 1 January 2010
- Published by Elsevier in Immunobiology
- Vol. 215 (1) , 70-80
Cytokine treatment of macrophage suppression of T cell activation
- 1 January 2010
- Published by Elsevier in Immunobiology
- Vol. 215 (1) , 70-80
Cytokine treatment of macrophage suppression of T cell activation